Showing results (31-40 of 179) with videos related to
Sort By:
Pageof 18
Cancer Treatment Reviews|November 22, 2015
Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapyXiangjiao Meng, Zhaoqin Huang, Feifei Teng, et al.Nuclear Medicine Communications|August 31, 2019
Association of radiomic features with epidermal growth factor receptor mutation status in non-small cell lung cancer and survival treated with tyrosine kinase inhibitorsChangbin Wang, Xinzhe Dong, Xiaorong Sun, et al.International Journal of Clinical Oncology|April 19, 2020
Management of gastrointestinal perforation related to radiationYawen Zheng, Wei Gao, Denial E Spratt, et al.Thoracic Cancer|October 13, 2017
Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centersFangjie Chen, Hui Luo, Ligang Xing, et al.Cancer Letters|July 10, 2017
PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challengesXiangjiao Meng, Yanli Liu, Jianjun Zhang, et al.Oncology Letters|January 2, 2016
Association between serum tumor markers and metabolic tumor volume or total lesion glycolysis in patients with recurrent small cell lung cancerPengyue Shi, Xue Meng, Mengmeng Ni, et al.Annals of Translational Medicine|March 14, 2022
PCGF1 is a prognostic biomarker and correlates with tumor immunity in gliomasJian Xie, Lili Qiao, Guodong Deng, et al.Journal of Applied Clinical Medical Physics|January 17, 2024
Feasibility evaluation of radiotherapy positioning system guided by augmented reality and point cloud registrationShaozhuang Zhai, Ziwen Wei, Xiaolong Wu, et al.Journal of Computer Assisted Tomography|November 10, 2023
Body Composition and Radiomics From 18 F-FDG PET/CT Together Help Predict Prognosis for Patients With Stage IV Non-Small Cell Lung CancerYi Zhang, Weiyue Tan, Zhonghang Zheng, et al.Journal of Cancer|January 4, 2021
GINS2 attenuates the development of lung cancer by inhibiting the STAT signaling pathwayDianmin Sun, Yuanyuan Zong, Jinling Cheng, et al.Pageof 18